Developing a framework of care for opioid medication misuse in community pharmacy

Research in Social and Administrative Pharmacy

Volumn 12, Issue 2, 2016, Pages 293-301

  Cochran, Gerald ^a   Gordon, Adam J ^b,c   Field, Craig ^d   Bacci, Jennifer ^a   Dhital, Ranjita ^e   Ylioja, Thomas ^a   Stitzer, Maxine ^f   Kelly, Thomas ^a   Tarter, Ralph ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS AT EL PASO   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Adherence; Medication management; Opioid misuse; Qualitative research

Indexed keywords

NARCOTIC ANALGESIC AGENT;

HUMAN; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD; SUBSTANCE-RELATED DISORDERS;

ANALGESICS, OPIOID; COMMUNITY PHARMACY SERVICES; HUMANS; MODELS, ORGANIZATIONAL; PATIENT-CENTERED CARE; PHARMACISTS; PROFESSIONAL ROLE; SUBSTANCE-RELATED DISORDERS;

EID: 84959505295     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2015.05.001     Document Type: Article

References (48)

1. CDC. Morbidity and Mortality Weekly Report. Vital Signs: Overdoses of Prescription Opioid Pain Relievers d United States, 1999-2008. Atlanta, GA: Centers for Disease Control and Prevention; 2011.
2. Manchikanti L, Singh A. Therapeutic opioids: a tenyear perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008;11(2 suppl): S63-S88.
3. Knisely JS, Wunsch MJ, Cropsey KL, Campbell ED. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse. J Subst Abuse Treat 2008;35: 380-386.
4. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: the TROUP Study. Pain 2010;150: 332-339.
5. Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among druginvolved club-and street-based populations. Pain Med 2007;8:171-183.
6. Cicero TJ, Kurtz SP, Surratt HL, et al. Multiple determinants of specific modes of prescription opioid diversion. J Drug Issues 2011;41:283-304.
7. US Bureau of Labor Statistics. Occupational Outlook Handbook. Washington, DC: U.S. Bureau of Labor Statistics; 2014.
8. Redman R. Pharmacists receive high marks on trust. Chain Drug Rev 2012;34:2.
9. Dhital R, Whittlesea CM, Norman IJ, Milligan P. Community pharmacy service users' views and perceptions of alcohol screening and brief intervention. Drug Alcohol Rev 2010;29:596-602.
10. Cochran G, Field C, Lawson K, Erickson C. Pharmacists' knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: a survey of Utah and Texas pharmacists. J Pharm Health Serv Res 2013;4:71-79.
11. Nilsen P, Baird J, Mello MJ, et al. Asystematic review of emergency care brief alcohol interventions for injury patients. J Subst Abuse Treat 2008;35:184-201.
12. Havard A, Shakeshaft A, Sanson-Fisher R. Systematic review and meta-analyses of strategies targeting alcohol problems in emergency departments: interventions reduce alcohol-related injuries. Addiction 2008;103(3):368-376. discussion 377-368.
13. Beich A, Thorsen T, Rollnick S. Screening in brief intervention trials targeting excessive drinkers in general practice: systematic review and meta-analysis. BMJ 2003;327:536-542.
14. Jenkins RJ, McAlaney J, McCambridge J. Change over time in alcohol consumption in control groups in brief intervention studies: systematic review and meta-regression study. Drug Alcohol Depend 2009; 100:107-114.
15. Kaner EF, Dickinson HO, Beyer F, et al. The effectiveness of brief alcohol interventions in primary care settings: a systematic review. Drug Alcohol Rev 2009;28:301-323.
16. Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend 2009;99:280-295.
17. Humeniuk R, Ali R, Babor T, et al. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction 2012;107:957-966.
18. Zahradnik A, Otto C, Crackau B, et al. Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients. Addiction 2009;104:109-117.
19. Heather N, Bowie A, Ashton H, et al. Randomised controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addict Res Theory 2004;12:141-154.
20. Cipolle RJ, Strand L, Morley P. Pharmaceutical Care Practice: The Patient Centered Approach to Medication Management. United States: The McGraw-Hill Companies, Inc; 2012.
21. Cochran G, Woo B, Lo-Ciganic W, Gordon AJ, Donohue J, Gellad W. Defining non-medical use of prescription opioids within health care claims: a systematic review. Subst Abus 2015;36:192-202.
22. Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain 2013;154:2287-2296.
23. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. J AmMed Assoc 2011;305:1315-1321.
24. Gwira Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med 2014;174: 796-801.
25. WHO. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva, Switzerland:World Health Organization; 2009.
26. Braker LS, Reese AE, Card RO, Van Howe RS. Screening for potential prescription opioid misuse in a Michigan Medicaid population. Fam Med 2009; 41:729-734.
27. Novak SP, Herman-Stahl M, Flannery B, Zimmerman M. Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States. Drug Alcohol Depend 2009;100:63-70.
28. Amari E, Rehm J, Goldner E, Fischer B. Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review. Can J Psychiatry 2011;56:495.
29. Hudson TJ, Edlund MJ, Steffick DE, Tripathi SP, Sullivan MD. Epidemiology of regular prescribed opioid use: results from a national, population-based survey. J Pain Symptom Manage 2008;36:280-288.
30. Saitz R, Palfai TP, Cheng DM, et al. Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. J Am Med Assoc 2014;312(5):502-513.
31. Roy-Byrne P, Bumgardner K, Krupski A, et al. Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial. J Am Med Assoc 2014;312:492-501.
32. Wingood GM, DiClemente RJ. The ADAPT-ITT model: a novel method of adapting evidence-based HIV Interventions. J Acquir Immune Defic Syndr 2008;47(suppl 1):S40-S46.
33. Pirotte MJ, Buckley BA, Lerhmann JF, Tanabe P. Development of a screening and brief intervention and referral for treatment for ED patients at risk for undiagnosed hypertension: a qualitative study. J Emerg Nurs 2014;40:e1-9.
34. Klimas J, Cullen W, Field CA, Problem Alcohol/Drug Use Guideline Development Group. Problem alcohol use among problem drug users: development and content of clinical guidelines for general practice. Ir J Med Sci 2014;183:89-101.
35. Ornelas IJ, AllenC, VaughanC, WilliamsEC, NegiN. Vida PURA: a cultural adaptation of screening and brief intervention to reduce unhealthy drinkingamong Latino DAY laborers. Subst Abus 2014.
36. Nygaard P, Aasland OG. Barriers to implementing screening and brief interventions in general practice: findings from a qualitative study in Norway. Alcohol Alcohol 2011;46:52-60.
37. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007;19:349-357.
38. Miles MB, Huberman AM, Saldana J. Qualitative Data Analysis: A Methods Sourcebook. 3rd ed. Los Angeles: Sage; 2014.
39. Engel RJ, Schutt RK. The Practice of Research in Social Work. Los Angeles: SAGE; 2009.
40. Stake RE. The Art of Case Study Research. Thousand Oaks: Sage Publications; 1995.
41. Hallgren KA. Computing inter-rater reliability for observational data: an overview and tutorial. Tutor Quant Methods Psychol 2012;8:23-34.
42. Nvivo 10 [computer Program]. Burlington, MA: QSR International; 2012.
43. Viswanathan M, Kahwati LC, Golin CE, et al. Medication therapy management interventions in outpatient settings: a systematic review and metaanalysis. JAMA Intern Med 2015;175:76-87.
44. Avalere Health LLC. Exploring Pharmacists' Role in a Changing Healthcare Environment. Washington, DC: Avalere Health LLC; 2014.
45. American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc 2008;48:341-353.
46. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc 2005;45:566-572.
47. Perlroth D, Marrufo G, Montesinos A, et al. Medication Therapy Management in Chronically Ill Populations: Final Report. Burlingame, CA: Acumen, LLC; 2013.
48. Bacci JL, McGrath SH, Pringle JL, Maguire MA, McGivney MS. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: the Pennsylvania Project. J Am Pharm Assoc 2014;54: 584-593.